Skip to content
the patient investor

the patient investor

  • Market Analysis
  • Managing Risk
    • Bull/Bear Market Indicator
    • Stock Market Valuation
  • Mega Trends
    • Global population
    • Environmental damage
    • Decarbonization
      • Energy: The coming crisis
      • Lithium
    • Internet
    • Digital communication
    • Automation
    • Health care and medical science
    • Debt & Inflation
    • Globalization
    • Geopolitics and great power conflict
  • About
    • Colin Twiggs
    • Terms of Use
    • Privacy Policy
    • Contact Us
  • Subscribe
  • Login
Posted on February 20, 2012 by ColinTwiggs

Singapore SGX: Top Momentum stocks

Top Momentum stocks identified using 63-day Twiggs Momentum and $500,000 daily Value/Turnover filter:

Incredible Charts Stock Screen: 63-day Twiggs Momentum

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn

Related

CategoriesIndia & Singapore, Stock Markets TagsSGX, Singapore, Twiggs Momentum, Twiggs Money Flow

Post navigation

Previous PostPrevious Charles Munger: A Lesson on Elementary, Worldly Wisdom As It Relates To Investment Management & Business | The Big Picture
Next PostNext Singapore SGX: Potential breakouts

Login for the latest Market Analysis

  • Japan’s Debt Trap
  • US Market Snapshot
  • ASX Market Snapshot
  • Bitcoin Plunge Signals Risk-Off
  • RBA Admits Its Mistake
  • US Market Snapshot
  • ASX Market Snapshot
  • US Market Snapshot
  • ASX Market Snapshot
  • Trump Backs Down
  • US Market Snapshot
  • ASX Market Snapshot
  • US Labor Market and Cyclical Sectors Warn of a Contraction
  • US Market Snapshot
  • ASX Market Snapshot
  • Gold, silver signal tilt to a new monetary system
  • US Market Snapshot
  • ASX Market Snapshot
  • US Market Snapshot
  • ASX Market Snapshot
  • US Market Snapshot
  • ASX Market Snapshot
  • Platinum jumps to 17-year high
  • US Market Snapshot
  • ASX Market Snapshot
  • US Market Snapshot
  • ASX Market Snapshot
  • The real risk of a Fed rate cut
  • ASX selling pressure
  • China’s NBS Manufacturing PMI for November

Topics

Disclaimer

Everything contained in this web site, related newsletters, emails, discussions, training videos and conferences (collectively referred to as the “Material”) is intended for the purpose of teaching analysis, trading and investment techniques. Advice in the Material is provided for the general information of readers and viewers (collectively referred to as “Reader/s”) and does not have regard to any particular person’s investment objectives, financial situation or needs. Accordingly, no Reader should act on the basis of any information in the Material without properly considering its applicability to their financial circumstances. If not properly qualified to do this for themselves, Readers should seek professional advice.

Investing and trading involves risk of loss. Past results are not necessarily indicative of future results.

The decision to invest or trade is for the Reader alone. We expressly disclaim all and any liability to any person, with respect of anything, and of the consequences of anything, done or omitted to be done by any such person in reliance upon the whole or any part of the Material.

© Copyright 2016 - 2026 The Patient Investor Pty Ltd. All rights reserved.
Powered by WordPress / WordPress Maintenance Service By Website Helper